LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT, AND DNA SUPPRESSION

被引：0

作者：

Reddy, K. Rajender ^{[1
]}

Curry, Michael P. ^{[2
]}

Bae, Ho S. ^{[3
]}

Dieterich, Douglas T. ^{[4
]}

Ankoma-Sey, Victor ^{[5
]}

Pan, Calvin Q. ^{[6
]}

Hann, Hie-Won L. ^{[7
]}

Tong, Myron J. ^{[8
]}

Kim, W. Ray ^{[9
]}

Kwo, Paul Yien ^{[9
]}

Frazier, Lynn ^{[10
]}

Cox, Kimmi ^{[11
]}

Milligan, Scott ^{[11
]}

Afdhal, Nezam H. ^{[2
]}

机构：

[1] Univ Penn, Philadelphia, PA 19104 USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[3] St Vincents Med Ctr, Asian Pacific Liver Ctr, Los Angeles, CA USA

[4] Mt Sinai Sch Med, New York, NY USA

[5] Liver Associates Texas Pa, Houston, TX USA

[6] NYU Sch Med, NYU Langone Hlth, New York, NY USA

[7] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[8] Huntington Med Res Inst, Ctr Liver, Pasadena, CA USA

[9] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[10] Liver Wellness Ctr, Little Rock, AR USA

[11] Trio Hlth Analyt, La Jolla, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

487

引用

页码：309A / 309A

页数：1

共 3 条